| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.088 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.013 | 0.8 |